The effective use of ADA in bioprocessing, though, requires a multidisciplinary team, from a program lead and subject-matter ...

People with diabetes have a higher risk of developing Alzheimer's disease (AD) raising a possible link between the cells that ...

Reusing buffers in downstream operations would help biopharmaceutical manufacturers significantly reduce water consumption, making production more sustainable and cost efficient.

A new, streamlined AAV purification process that is both universal and scalable could ease commercialization constraint.

Lumi is available for early-stage process development. Reach Industries hopes to eventually offer the system for use in GMP compliancy.

Researchers identify glucose usage as one major divergence betweenT cells expanding in vitro versus those expanding in vivo.

Antibody-RNA Conjugates represent a significant advancement in the treatment of challenging and rare diseases with unmet medical need.

Taking longer to enter the dream phase can disrupt the ability to consolidate memories and interfere with emotion regulation.

Researchers designed oligopeptides that could co-assemble with therapeutic cargoes to create nanoparticles that improved the ...

I don’t think proteomics will win over genomics," Sanghera said. "They go hand-in-glove. We’ve been overly focused [on genomics], and now we’re going to see an emergence of proteomics. And when the ...

The CuRVE framework and its implementation in eFLASH mark a significant advancement in volumetric single-cell analysis.

The proof-of-concept demonstrates the power of pairing AI with lab orchestration solutions to automate molecular screening ...